Akira Science Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 5

Akira Science General Information

Description

Developer of a degradable polymer designed for the integration and customization of implants. The company offers pliable three-dimensional-printed scaffolds for soft tissue engineering or filaments that are non-toxic, degradable, and biocompatible, and lead to enhanced cell-material interaction, enabling medical professionals to get access to suitable scaffold designs to tailor the biological response.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Hornsgatan 119
  • 117 28 Stockholm
  • Sweden
+46 072-403
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Medical Supplies
Corporate Office
  • Hornsgatan 119
  • 117 28 Stockholm
  • Sweden
+46 072-403

Akira Science Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Akira Science Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Accelerator/Incubator 17-Jun-2024 Completed Generating Revenue
5. Later Stage VC 01-Jan-2024 Completed Generating Revenue
4. Grant 01-Nov-2022 Completed Generating Revenue
3. Accelerator/Incubator 08-Feb-2022 Completed Generating Revenue
2. Accelerator/Incubator 01-Apr-2021 Completed Generating Revenue
1. University Spin-Out 01-Jan-2019 Completed Generating Revenue
To view Akira Science’s complete valuation and funding history, request access »

Akira Science Patents

Akira Science Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3946147-A1 Scaffolds for use in tissue engineering and method for preparing scaffolds Active 29-Mar-2019
EP-3946147-B1 Scaffolds for use in tissue engineering and method for preparing scaffolds Active 29-Mar-2019
EP-3946147-B8 Scaffolds for use in tissue engineering and method for preparing scaffolds Active 29-Mar-2019
EP-3946147-C0 Scaffolds for use in tissue engineering and method for preparing scaffolds Active 29-Mar-2019
ES-3060116-T3 Scaffolds for use in tissue engineering and method for preparing scaffolds Active 29-Mar-2019 A61L27/26
To view Akira Science’s complete patent history, request access »

Akira Science Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Akira Science Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Ready2Scale Accelerator/Incubator
Vinnova Government
Stockholm Innovation & Growth Accelerator/Incubator Minority
KTH Innovation Accelerator/Incubator
KTH Royal Institute of Technology University
To view Akira Science’s complete investors history, request access »

Akira Science FAQs

  • When was Akira Science founded?

    Akira Science was founded in 2019.

  • Where is Akira Science headquartered?

    Akira Science is headquartered in Stockholm, Sweden.

  • What is the size of Akira Science?

    Akira Science has 2 total employees.

  • What industry is Akira Science in?

    Akira Science’s primary industry is Therapeutic Devices.

  • Is Akira Science a private or public company?

    Akira Science is a Private company.

  • What is Akira Science’s current revenue?

    The current revenue for Akira Science is .

  • How much funding has Akira Science raised over time?

    Akira Science has raised $4.05M.

  • Who are Akira Science’s investors?

    Ready2Scale, Vinnova, Stockholm Innovation & Growth, KTH Innovation, and KTH Royal Institute of Technology have invested in Akira Science.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process